首页 | 本学科首页   官方微博 | 高级检索  
     

骨形态发生蛋白-2基因修饰的组织工程化骨修复羊胫骨干骨缺损
引用本文:Dai KR,Xu XL,Tang TT,Zhu ZA,Yu CF,Xu M,Zhu LL,Hao YQ,Lou JR. 骨形态发生蛋白-2基因修饰的组织工程化骨修复羊胫骨干骨缺损[J]. 中华医学杂志, 2003, 83(15): 1345-1349
作者姓名:Dai KR  Xu XL  Tang TT  Zhu ZA  Yu CF  Xu M  Zhu LL  Hao YQ  Lou JR
作者单位:1. 200011,上海第二医科大学附属第九人民医院骨科
2. Department of Orthopaedics, Washington University School of Medicine
基金项目:上海市重点科技发展项目 (0 1JC14 0 2 8),上海市科委国际合作项目 (0 14 3 0 70 2 1)
摘    要:目的 评价腺病毒介导的人骨形态发生蛋白2(Adv-hBMP-2)基因转染的组织工程化人工骨对大动物长骨干骨缺损的修复效果。方法 建立羊胫骨干骨缺损模型(2.6cm),单侧(右)植人体外构建的组织工程化骨,26只羊分为5组:(1)Adv-hBMP-2转染的骨髓间充质干细胞(BMSC)加煅烧骨(CB)组(9侧);(2)腺病毒介导的β-半乳糖苷酶(Adv-βgal)基因转染的BMSC加CB组(6侧);(3)未转染的BMSC加CB组(6侧);(4)单纯CB组(3侧);(5)未治疗组(2侧)。分期行X线、计量组织学检查和生物力学测定。结果 X线:4~8周,Adv-hBMP-2转染组的羊胫骨干骨缺损内有明显骨痂形成;26周,(1)、(2)、(3)、(4)和(5)组的完全愈合率,分别为5/8、1/5、0/5、0/2、0/1。计量组织学示,与其他组相比,1组的新生骨量最多,并有皮质骨形成;第1组移植骨的压缩载荷和弹性模量明显大于其他各组。结论 hBMP-2基因修饰的组织工程化人工骨可以修复大动物(羊)负重骨(胫骨)的节段性缺损。

关 键 词:骨形态发生蛋白-2 基因修饰 组织工程化骨 修复 胫骨干骨缺损 骨代用品 骨再生
修稿时间:2002-12-23

BMP-2 gene modified tissue-engineered bone repairing segmental tibial bone defects in goats
Dai Ke-rong,Xu Xiao-liang,Tang Ting-ting,Zhu Zhen-an,Yu Chao-feng,Xu Min,Zhu Liu-long,Hao Yong-qiang,Lou Jue-ren. BMP-2 gene modified tissue-engineered bone repairing segmental tibial bone defects in goats[J]. Zhonghua yi xue za zhi, 2003, 83(15): 1345-1349
Authors:Dai Ke-rong  Xu Xiao-liang  Tang Ting-ting  Zhu Zhen-an  Yu Chao-feng  Xu Min  Zhu Liu-long  Hao Yong-qiang  Lou Jue-ren
Affiliation:Department of Orthopaedics, Ninth People's Hospital, Shanghai Second Medical University, Shanghai 200011, China.
Abstract:OBJECTIVE: To evaluate the effectiveness of the tissue-engineered bone substitute loaded with adenovirus mediated human bone morphogenetic protein-2 gene (Adv-hBMP-2) transfected bone marrow derived mesenchymal stem cells (BMSC) in the repair of diaphyseal segmental bone defect of large animal. METHODS: The right tibial bone defects (2.6 cm) model of 26 goats were established and divided into 5 groups: I. Adv-hBMP-2 transfected BMSC/calcined bone (CB) group (n = 9); II. adenovirus-beta-galactosidase (Adv-betagal) gene transfected BMSC/CB group (n = 6); III. untransfected BMSC/CB group (n = 6); IV. single CB group (n = 3); VI. untreated group (n = 2). The above tissue-engineered bone substitutes were implanted in the bone defects respectively except group VI. Roentgenography, histomorphometrical analysis and biomechanical measurement were studied at various times. RESULTS: X-ray: at 4 - 8th weeks after implantation, more bony callus was found in the bone defects of group I. The complete healing rates of group I, II, III, IV, and V were 5/8, 1/5, 0/5, 0/2, 0/1 respectively at 26th week after implantation. Histomorphometrical analysis showed much more new bony callus including cortical bone formed in group I than those of other groups. The compression strength of the implanted bone substitute of group I is significantly higher than those of group II and III. CONCLUSION: The tissue-engineered bone substitute loaded with human BMP-2 gene transfected BMSC can repair diaphyseal segmental bone defect of large animal (goat).
Keywords:Bone morphogenetic proteins  Gene therapy  Stem cells  Bone regenerations  Bone substitutes  Human engineering
本文献已被 CNKI 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号